Author:
Gobbi Paolo G.,Rosti Vittorio,Valentino Francesco,Bonetti Elisa,Merli Francesco,Stelitano Caterina,Dondi Alessandra,Quarta Giovanni,Falorio Simona,Federico Massimo
Subject
Cancer Research,Oncology,Hematology,General Medicine
Reference14 articles.
1. Long-term results from MOPPEBVCAD chemotherapy with optional limited radiotherapy in advanced Hodgkin's disease;Gobbi;Blood,1998
2. MOPPEBVCAD chemotherapy with limited and conditioned radiotherapy in advanced Hodgkin's lymphoma. 10-year results, late toxicity and second tumors;Gobbi;Clin Cancer Res,2006
3. Standard and increased-dose BEACOPP chemotherapy compared with COPP-ABVD for advanced Hodgkin's disease;Diehl;N Engl J Med,2003
4. Comparable 3-year outcome following ABVD or BEACOPP first-line chemotherap, plus preplanned high-dose salvage, in advanced Hodgkin Lymphoma (HL): a randomized trial of the Michelangelo, GITIL and IIL cooperative groups;Gianni;J Clin Oncol,2008
5. ABVD vs. BEACOPP vs. CEC for the initial treatment of patients with advanced Hodgkin lymphoma. Results from the HD2000 GISL Trial;Federico;J Clin Oncol,2009
Cited by
6 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献